Assignee
RELAY THERAPEUTICS INC
US·14 granted patents·13 pending applications·63 citations·filing 2017–2025
Top patents by PatentIndex Score
27 records- 0196US10934302B1SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·44 cites·7 claims
- 0291US12084447B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Sep 10, 2024·2 cites·20 claims
- 0388US12219327B2Substituted isoindolines as PI3K-alpha inhibitorsRELAY THERAPEUTICS INC·Filed 2023·Granted Feb 4, 2025·1 cites·6 claims
- 0486US11701354B2Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Jul 18, 2023·3 cites·40 claims
- 0585US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 0684US11529347B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Dec 20, 2022·4 cites·8 claims
- 0783US11780845B2FGFR inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Granted Oct 10, 2023·1 cites·2 claims
- 0882US11890281B2SHP2 phosphatase inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·1 cites·27 claims
- 0981US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 1078US12331056B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Granted Jun 17, 2025·0 cites·21 claims
- 1174US12152034B2FGFR inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·1 cites·19 claims
- 1271US2024122925A1Shp2 phosphatase inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1368US2026035335A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1466US2025313524A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1565US2022315586A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1663US2026041669A1Solid forms of a cdk inhibitorRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1759US2024368122A1Jak2 inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1858US12581252B2Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitorsRELAY THERAPEUTICS INC·Filed 2021·Granted Mar 17, 2026·0 cites·20 claims
- 1958US2025388565A1Estrogen receptor alpha degraders and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2058US2025243204A1Fgfr inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2157US2024190855A1Cdk inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2256US2025090540A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2354US2025084048A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2454US2025019380A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2552US12522605B2FGFR inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Jan 13, 2026·0 cites·20 claims
- 2649US2020392161A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2740US12138263B2Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2024·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →